Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Prophylactic Tocilizumab Before Anti-CD19 CAR-T Therapy for R/R Lymphoma

Paolo Caimi, MD, Case Western Reserve University, discusses findings from a study examining the use of prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T cells in patients with relapsed/refractory lymphoma.

 

Advertisement

Advertisement

Advertisement

Advertisement